AULIS CAPITAL US ADVISOR, LLC

Thesis

Aulis Capital is a venture capital firm established in 2025 and headquartered in Palo Alto, California. The firm's primary focus is on investing in the healthcare industry, aiming to build a healthier and more equitable world through innovation. Aulis Capital partners with early and growth-stage companies, leveraging scientific, analytical, and investment expertise to accelerate advancements in medical technology and patient care. Their investment thesis centers on identifying and supporting transformative innovations within the healthcare sector, specifically in medical devices, diagnostics, and digital health solutions. Aulis Capital emphasizes a global approach with offices in Palo Alto, Shanghai, Beijing, and Hong Kong, actively facilitating strategic partnerships by connecting global companies with Asia's engineering and clinical development strengths. Their strategy involves partnering with early and growth-stage companies, supporting cutting-edge solutions that promote efficiency and personalization in healthcare. They also provide access to a robust ecosystem through their proprietary network of top-tier hospitals, academic institutions, and healthcare companies globally. While specific fund sizes and AUM are not publicly disclosed, Aulis Capital has made at least two disclosed investments. Their typical investment stage preference appears to be early and growth stages. The firm operates as an Exempt Reporting Adviser (ERA).

Related lists

• Seed-stage Healthcare investors
• Series C+ Healthcare investors
• Seed investors based in Palo Alto, CA